Pharmaceutical Technology on MSN
Mexico enlists Moderna to boost mRNA supply for respiratory diseases
Unlike the US, Mexico is bolstering its mRNA offerings with the help of Moderna’s portfolio.
Moderna (MRNA) stock is in focus as the company looks to sign a five year deal to deliver respiratory vaccines to Mexico. Read more here.
Add Yahoo as a preferred source to see more of our stories on Google. As SARS-CoV-2 has become endemic At IDWeek 2025, (the joint annual meeting of the Infectious Diseases Society of America, the ...
President Sheinbaum announced on Monday the signing of an agreement between Mexico's Health Ministry, state-owned medical ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative ...
In an observational study involving nearly 440,000 veterans, both the BNT162b2 vaccine and the mRNA-1273 vaccine were highly effective at preventing infection, hospitalization, and death from Covid-19 ...
CAMBRIDGE, Mass. & BASEL, Switzerland--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new ...
CAMBRIDGE, MA / ACCESS Newswire / December 15, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results